Skip to Main Content

Advertisement

Skip Nav Destination

Correction: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

Clin Cancer Res (2015) 21 (9): 2192.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Xiancui Zhu
  • Mengchen Xu
  • Jinrong Sun
  • Dianjun Guo
  • Yiwei Zhang
  • Shuangliu Zhou
  • Shaowu Wang
European Journal of Organic Chemistry (2021) 2021 (37): 5213.
  • X Jiang
  • Y Bao
  • H Liu
  • X Kou
  • Z Zhang
  • F Sun
  • Z Qian
  • Z Lin
  • X Li
  • X Liu
  • L Jiang
  • Y Yang
Oncogene (2017) 36 (50): 6850.
Close Modal

or Create an Account

Close Modal
Close Modal